Genenta Science SPA
GNTA3.770USD
+0.060+1.62%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
68.95MMarket Cap
--P/E TTM
Genenta Science SPA
3.770
+0.060+1.62%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-15.37%-4.18M
72.85%-2.06M
25.29%-3.62M
-195.38%-7.58M
---4.85M
---2.57M
Net income from continuing operations
0.25%-4.87M
40.25%-4.04M
23.24%-4.89M
-219.99%-6.76M
---6.37M
---2.11M
Operating gains losses
5.07%22.39K
4.68%22.13K
540.52%21.31K
651.62%21.14K
--3.33K
--2.81K
Other non-cash items
-10.31%31.40K
-22.05%31.71K
-46.78%35.01K
65.56%40.69K
--65.78K
--24.57K
Change in working capital
-97.31%23.71K
230.47%1.69M
-8.43%880.57K
-79.98%-1.30M
--961.60K
---721.30K
-Change in prepaid expenses
14.97%-149.93K
316.37%817.26K
-121.75%-176.32K
68.99%-377.72K
--810.60K
---1.22M
-Change in other current assets
-93.00%76.93K
224.03%622.89K
226.19%1.10M
-213.34%-502.23K
---871.02K
--443.11K
-Change in other current liabilities
-253.75%-120.00K
273.23%198.50K
-14.71%78.05K
-144.10%-114.58K
--91.50K
--259.81K
Cash from non-recurring investing activities
Cash from operating activities
-15.37%-4.18M
72.85%-2.06M
25.29%-3.62M
-195.38%-7.58M
---4.85M
---2.57M
Investing cash flow
Net cash from continuing investing activities
91.95%2.60K
-84.97%1.87K
-94.42%1.35K
342.13%12.44K
--24.26K
--2.81K
Capital expenditures
91.95%2.60K
-84.97%1.87K
-94.42%1.35K
342.13%12.44K
--24.26K
--2.81K
Net cash flow from disposal of fixed assets
91.95%2.60K
-84.97%1.87K
-94.42%1.35K
342.13%12.44K
--24.26K
--2.81K
Net cash flow from investment products
152.88%2.59M
143.07%4.30M
---4.89M
---9.99M
----
----
Cash from non-current investing activities
Net cash flow from investing activities
152.81%2.58M
142.99%4.30M
-20064.07%-4.89M
-355444.51%-10.00M
---24.26K
---2.81K
Financing cash flow
Cash flow from continuous financing activities
-100.00%0.00
--270.88K
--531.00
--0.00
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
----
----
----
----
----
--0.00
Proceeds from stock option exercised by employees
----
----
----
----
--0.00
--0.00
Net cash flow from other financing activities
-100.00%0.00
--270.88K
--531.00
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.00%0.00
--270.88K
--531.00
--0.00
--0.00
--0.00
Net cash flow
Beginning cash balance
-49.33%6.19M
-87.61%3.69M
-64.77%12.21M
-19.99%29.79M
--34.67M
--37.24M
Current period cash flow changes
81.15%-1.61M
114.20%2.50M
-74.76%-8.52M
-584.37%-17.58M
---4.88M
---2.57M
Effect of exchange rate changes
-17.31%-7.37K
---16.08K
---6.28K
----
----
----
Ending cash balance
24.12%4.58M
-49.33%6.19M
-87.61%3.69M
-64.77%12.21M
--29.79M
--34.67M
Free cash flow
-15.40%-4.18M
72.87%-2.06M
25.64%-3.63M
-195.54%-7.59M
---4.88M
---2.57M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
